PUBLICATIONS

Each publication below is a story:
Often a story and adventure. It's science, epidemiology and more

1. Miller FD. The Effects of Chemical Immunosuppression on SV40 Tumor Transplantation Immunity In Vivo [Master]. Knoxville, Tennesse: University of Tennesse, Knoxville; 1968 (Dec).

2. Miller FD. Immunological Aspects of Striated Muscle Transplantation. . Third Annual Medical Congress. Pahlavi Medical School, Shiraz, Iran; 1972.

3. Miller FD. Schistosomiasis in rural Egypt : a report of U. S.-Egyptian River Nile and Lake Nasser research project. In: Environmental Research Laboratory (Athens Ga.), editor. EPA: Environmental health effects research series. Athens, Ga.:

Environmental Research Laboratory, Office of Research and Development, U. S. Environmental Protection Agency : Springfield, Va. : available through National Technical Information Service; 1978. p. xviii, 206 p.

4. Miller FD. Studies on Schistosomiasis in Rural Egypt Following the Construction of the Aswan High Dam [Dissertation]. Ann Abor, Michigan: University of Michigan; 1978.

5. Miller FD, Hussein M, Mancy KH, and , Hilbert MS. Aspects of Environmental Health Impacts of the Aswan High Dam on Rural Populations in Egypt. Progress in Water Technology 1978; 11((1/2)): 173-80.

6. Miller FD. Environmental health impacts of the Aswan High Dam in Egypt. . International Symposium on Engineering Science and Medicine in the Prevention of Tropical Water-Related Disease. London School of Tropical Medicine and Hygiene and the Institution of Civil Engineers, London, England.; 1979.

7. Miller FD, Mancy KH, King C, Hilbert MS, Hussein M. Schistosome Patterns in Egypt. Lancet 1979; 6: 749.

8. Miller FD. Human intestinal parasitic infections and environmental health factors in rural Egyptian communities : a report of the U. S.-Egyptian River Nile and Lake Nasser Research Project. In: Environmental Research Laboratory (Athens Ga.), Project. US-ERNaLNR, editors. EPA. Athens, Ga.: Environmental Research Laboratory, Office of Research and Development, U. S. Environmental Agency; 1980. p. x, 151 p.

9. Miller FD. Human intestinal parasitic infections and environmental health factors in rural Egyptian communities : a report of the U.S.-Egyptian River Nile and Lake Nassar research project. In: Environmental Research Laboratory (Athens Ga.), Project. US-ERNaLNR, editors. EPA. Athens, Ga. : Springfield, Va.: Environmental Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency ; Available to the public through the National Technical Information Service; 1980. p. x, 151 pages.

10. Miller FD. A brief Assessment of Water Supply and Waste Disposal Systems in Developing Countries. Approtech 1980; 3.

11. Miller F, Hussein M, Mancy KH, Hilbert MS, Monto AS, Barakat RM. An epidemiological study of Schistosoma haematobium and S. mansoni infection in thirty-five rural Egyptian villages. Tropical and geographical medicine 1981; 33(4): 355-65.

12. King CL, Miller FD, Hussein M, Barkat R, Monto AS. Prevalence and intensity of Schistosoma haematobium infection in six villages of upper Egypt. The American journal of tropical medicine and hygiene 1982; 31(2): 320-7.

13. Miller FD, El-Hakim SM, Bruce JI. An epidemiological investigation of health risks related to solid waste salvage and recycling in an Egyptian community. Tropical and geographical medicine 1982; 34(3): 241-9.

14. Monto AS, Miller FD, Maassab HF. Evaluation of an attenuated, cold-recombinant influenza B virus vaccine. J Infect Dis 1982; 145(1): 57-64.

15. Miller FD. Problems of water storage in the rural village home: the Egyptian zir. The Journal of tropical medicine and hygiene 1984; 87(2): 53-9.

16. Miller FD, Brilliant LB, Copeland R. Polybrominated biphenyls in lactating Michigan women: Persistence in the population. Bulletin of Environmental Contamination and Toxicology 1984; 32(1): 125-33.

17. Miller FD, Hicks SP, D'Amato CJ, Landis JR. A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. Am J Epidemiol 1984; 120(3): 331-41.

18. Miller FD, Monto AS, DeLong DC, Exelby A, Bryan ER, Srivastava S. Controlled trial of enviroxime against natural rhinovirus infections in a community. Antimicrob Agents Chemother 1985; 27(1): 102-6.

19. Miller FD. Boiling drinking water programs: A critical look. . Waterlines 1986; 5((1)): 2-5.

20. Miller FD. Water consumption and demand measurements for single family households: A pilot approach. . Journal of Environmental Health 1987; 50: 13-7. .

21. Miller FD, Reed DM, MacLean CJ. A prospective study of mortality and morbidity among carpenters in the Honolulu Heart Program Cohort. J Occup Med 1988; 30(11): 879-82.

22. Miller FD, Michael JM. Environmental health education in Micronesia. Asia Pac J Public Health 1989; 3(1): 51-60.

23. Reed D, LaCroix, AZ, Karasek, RA, Miller, D., & MacLean, CA. Occupational strain and the incidence of coronary heart disease. American Journal of Epidemiology 1989; 129((3)): 495-502.

24. Curb JD, Reed DM, Miller FD, Yano K. Health status and life style in elderly Japanese men with a long life expectancy. J Gerontol 1990; 45(5): S206-11.

25. Kloos H, Higashi G, Schinski VD, Mansour NS, Murrell KD, Miller FD. Water contact and Schistosoma haematobium infection: a case study from an upper Egyptian village. Int J Epidemiol 1990; 19(3): 749-58.

26. Miller FD. The Impact of the United Nations International Decade for Drinking Water Supply and Sanitation on Schistosomiasis. A Special Report to the United Nations General Assembly: . In: Schistosomiasis, editor. IDWSSD ed. United Nations Secretary General at the World Health Organization, Geneva: World Health Organization, Geneva; 1990.

27. Kungskulniti N, Pulket C, Miller FD, Smith KR. Solid waste scavenger community: an investigation in Bangkok, Thailand. Asia Pac J Public Health 1991; 5(1): 54-65.

28. Miller FD. Bacterial contamination of water resources on Moen, Truk Islands, Federated States of Micronesia. In: Geological S, University of Hawaii at M, editors. Technical memorandum ;no 83. Honolulu, Hawaii: Water Resources Research Center, University of Hawaii at Manoa; 1991. p. xiii, 45 p.

29. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD. High HCV prevalence in Egyptian blood donors. Lancet 1992; 340(8816): 427.

30. Barakat R, Farghaly A, el-Sawy MF, et al. An epidemiological assessment of Ambrosia maritima on the transmission of schistosomiasis in the Egyptian Nile Delta. Trop Med Parasitol 1993; 44(3): 181-6.

31. Kamel M, Kuhns MC, Miller FD, et al. High hepatitis C seroprevalence and serum viremia with normal alanine aminotransferase levels among blood donors and rural villagers in Egypt. . Hepatology 1993; 18(4(Part 2)).

32. Kamel M, Miller F, Troonen H, Ghaffar YA. Independent association of HBsAg and HCV with hepatocellular carcinoma (HCC) in an area of high endemicity: Egypt. Hepatology 1993; 18(4): 2.

33. Miller FD, Reed DM, Banta J. Sugarcane workers: morbidity and mortality. Hawaii Med J 1993; 52(11): 300-3, 6.

34. Miller FD, Reed DM, MacLean CJ. Mortality and morbidity among blue and white collar workers in the Honolulu Heart Program cohort. Int J Epidemiol 1993; 22(5): 834-7.

35. Kamel M, El Manialawi M, Miller FD. Recombinant hepatitis B vaccine immunogenicity in presence of hepatitis C virus seropositivity. Lancet 1994; 343(8896): 552.

36. Kamel MA, Miller FD, el Masry AG, et al. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 1994; 88(5): 501-9.

37. Barakat R, el Masry AG, Farghaly A, et al. Impact of population-based selective chemotherapy on prevalence and intensity of Schistosoma mansoni infections in the Nile Delta: Kafr El Sheikh. Tropical and geographical medicine 1995; 47(6): 266-70.

38. Barakat R, Farghaly A, el Masry AG, elSayed MK, Husein MH, Miller FD. Schistosoma mansoni in the Nile Delta, Egypt. A large scale epidemiological study in Kafr El Sheikh Governorate. Tropical and geographical medicine 1995; 47(6): 259-65.

39. Barakat R, Farghaly A, Morshidy HN, et al. Patterns of infection, incidence and reinfection with Schistosoma mansoni in Nile Delta Governorate: Kafr El Sheikh. Tropical and geographical medicine 1995; 47(6): 270-7.

40. Kamel MA, Troonen H, Kapprell HP, el-Ayady A, Miller FD. Seroepidemiology of hepatitis E virus in the Egyptian Nile Delta. J Med Virol 1995; 47(4): 399-403.

41. El Sayed MK, Barakat R, Farghaly A, et al. The impact of passive chemotherapy on Schistosoma mansoni prevalence and intensity of infection in the Egyptian Nile Delta. The American journal of tropical medicine and hygiene 1997; 57(3): 266-71.

42. Miller FD. High seroprevalence of hepatitis A, B, C, and E virus in an Egyptian village in the Nile Delta. The American journal of tropical medicine and hygiene 1997; 57(3): 251.

43. Miller FD. Schistosomiasis and Hepatitis C Virus in Egypt. . Health Issues in the Middle East. University of Michigan. Ann Arbor, Michigan.: University of Michigan. Ann Arbor, Michigan.; 1997.

44. Barakat R, Farghaly A, El Morshidy HN, Hassan M, Miller FD. Impact of National Schistosomiasis Control Program in Kafr el Sheikh Governorate, Nile Delta, Egypt: An independent evaluation. Journal of the Egyptian Public Health Association 1998; 73(5,6): 737-53.

45. Rashida Barakat, Azza Farghaly, Hala N. El Morshidy, Mohammed Hassan, Miller FD. Impact of National Schistosomiasis Control Program in Kafr el Sheikh Governorate, Nile Delta, Egypt: An independent evaluation. The Journal of the Egyptian Public Health Association 1998; LXXIII: ((5,6) ): 737-53.

46. Talaat M, Miller FD. A mass chemotherapy trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt. The American journal of tropical medicine and hygiene 1998; 59(4): 546-50.

47. Nerurkar VR, Woodward CL, Nguyen HT, et al. Lack of association between acquisition of TT virus and risk behavior for HIV and HCV infection in Vietnam. Int J Infect Dis 1999; 3(4): 181-5.

48. Talaat M, El-Ayyat A, Sayed HA, Miller FD. Emergence of Schistosoma mansoni infection in upper Egypt: the Giza governorate. The American journal of tropical medicine and hygiene 1999; 60(5): 822-6.

49. El-Khoby T, Hussein MH, Galal N, Miller FD. Epidemiology 1, 2, 3: origins, objectives, organization, and implementation. The American journal of tropical medicine and hygiene 2000; 62(2 Suppl): 2-7.

50. Hussein MH, El-Sayed MK, Talaat M, El-Badawy A, Miller FD. Epidemiology 1, 2, 3: study and sample design. The American journal of tropical medicine and hygiene 2000; 62(2 Suppl): 8-13.

51. Katz AR, Miller FD. The role of epidemiology in graduate medical education. Hawaii Med J 2002; 61(5): 102-3.

52. Lasher LE, Elm JL, Hoang Q, et al. A case control investigation of hepatitis C risk factors in Hawaii. Hawaii Med J 2005; 64(11): 296-300, 2-4.

53. Li F, Park SY, Ayers TL, et al. Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002. Emerg Infect Dis 2005; 11(8): 1205-10.

54. Shimizu SM, Chow DC, Katz AR, Richmond-Crum S, Miller FD. Ethnic differences in HIV disease progression: a comparison of Asian/Pacific Islanders and Whites living in Hawaii. Ethn Dis 2006; 16(1): 262-7.

55. Li F, Arnsberger P, Miller FD. Profile of methicillin-resistant Staphylococcus aureus among nursing home residents in Hawai'i. Hawaii Med J 2010; 69(5): 126-9.

56. Li F, Miller FD, Effler PV. Epidemiology of methicillin-resistant Staphylococcus aureus among incarcerated population in Hawai'i, 2000-2005. Hawaii Med J 2010; 69(4): 99-102.

57. Miller FD. Population incidence estimates for hepatitis C virus infection in Egypt. International Journal of Infectious Diseases 2010; 14(PIIS1201971210004959.pdf): e379.

58. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A 2010; 107(33): 14757-62.

59. Ruth Bastable G, UK, Sylvie Briand c-ootI, Respiratory , Diseases HaPfuatWH, et al. The Silent Pandemic. Tackling Hepatitis C with Policy Innovation. The Economist. 2012.

60. Chemaitelly H, Abu-Raddad LJ, Miller FD. An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt. PLoS One 2013; 8(7): e69803.

61. Miller FD, Abu-Raddad LJ. Quantifying current hepatitis C virus incidence in Egypt. J Viral Hepat 2013; 20(9): 666-7.

62. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013; 13: 288.

63. Cuadros DF, Branscum AJ, Miller FD, Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications. Hepatology 2014; 60(4): 1150-9.

64. Miller FD. Epidemiology and Prevention of HCV in Eygpt. BioVisionAlexandria 2014 Conference Bibliotheca Alexandrina, Alexandria, Egypt
Invited Presentation Grand Hall of the Bibliotheca Alexandrina 2014.

65. Mohamoud YA, Miller FD, Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker. World J Gastroenterol 2014; 20(36): 12734-52.

66. Perumalswami PV, Miller FD, Orabee H, et al. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community. Liver international : official journal of the International Association for the Study of the Liver 2014; 34(2): 253-8.

67. Benova L, Awad SF, Miller FD, Abu-Raddad LJ. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology 2015; 61(3): 834-42.

68. Cuadros DF, Branscum AJ, Miller FD, Awad SF, Abu-Raddad LJ. Are Geographical "Cold Spots" of Male Circumcision Driving Differential HIV Dynamics in Tanzania? Front Public Health 2015; 3: 218.

69. Cuadros DF, Miller FD, Nagelkerke N, Abu-Raddad LJ. Association between HCV infection and diabetes type 2 in Egypt: is it time to split up? Ann Epidemiol 2015; 25(12): 918-23.

70. Hassanin FS, Schaalan MF, Kamal KM, Miller FD. An Initial Investigation of Do Not Resuscitate Acceptance in Egypt. American Journal of Hospice and Palliative Medicine 2015.

71. Miller FD, Elzalabany MS, Hassani S, Cuadros DF. Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation. World J Hepatol 2015; 7(28): 2849-58.

72. Chuang E, Lim E, Milne C, et al. Human Papillomavirus at Multiple Sites Associated with Anal Squamous Intraepithelial Lesions in HIV-Seropositive Individuals. Ann Clin Cytol Pathol 2016; 2(4).

73. Hassanin FS, Schaalan MF, Kamal KM, Miller FD. An Initial Investigation of Do Not Resuscitate Acceptance in Egypt. Am J Hosp Palliat Care 2016; 33(9): 823-8.

74. Miller FD. Hepatitis C virus in Arabian Gulf countries: Implications and priorities. Int J Infect Dis 2016; 46: 115.

75. Mohsen DA, Hosny S, Morshedy N, Miller FD, Elzalabany MS. Prevalence of Hepatitis C Virus Infection in Egyptian Patients with Rheumatoid Arthritis ACR 2017; (Abstract).

76. Soliman G, Negm MS, Elzalabany M, et al. Is treatment of hepatitis C with controlled generic direct acting antiviral drugs effective? An Egyptian experience. Journal of Hepatology 2018; 68: S276.

77. Soliman G, Negm MS, Elzalabany MS, et al. High efficacy and safety of sofosbuvir plus daclatasvir for treatment of hepatitis C virus genotype 4: a real life Egyptian experience. Submitted 2018.

78. Miller FD. Adapting Epidemologic Methods to Investigate Iatrogenic Transmission and Evaluate Interventions in Egypt: Understanding Exposure Epidemiology. Alex-Health 2019. Alexandria, Egypt; 2019.

79. Soliman G, Elzalabany MS, Hassanein T, Miller FD. Mass screening for hepatitis B and C in Southern Upper Egypt. BMC Public Health 2019; 19(1): 1326.

80. Cuadros DF, Miller FD. Barriers Associated with Effective Use of Insecticide Treated Nets and Geographical Identification of Vulnerable Children at Risk of Malaria in sub-Saharan Africa. Malaria Journal 2020.

81. Hernandez A, Correa-Agudelo E, Kim H, et al. On the impact of early non-pharmaceutical interventions as containment strategies against the COVID-19 pandemic. Journal of Infection 2020; YJINF-D-20-02111.

Publications: Recognitions

PUBLICATIONS

1. Miller FD. The Effects of Chemical Immunosuppression on SV40 Tumor Transplantation Immunity In Vivo [Master]. Knoxville, Tennesse: University of Tennesse, Knoxville; 1968 (Dec).

2. Miller FD. Immunological Aspects of Striated Muscle Transplantation. . Third Annual Medical Congress. Pahlavi Medical School, Shiraz, Iran; 1972.

3. Miller FD. Schistosomiasis in rural Egypt : a report of U. S.-Egyptian River Nile and Lake Nasser research project. In: Environmental Research Laboratory (Athens Ga.), editor. EPA: Environmental health effects research series. Athens, Ga.:

Environmental Research Laboratory, Office of Research and Development, U. S. Environmental Protection Agency : Springfield, Va. : available through National Technical Information Service; 1978. p. xviii, 206 p.

4. Miller FD. Studies on Schistosomiasis in Rural Egypt Following the Construction of the Aswan High Dam [Dissertation]. Ann Abor, Michigan: University of Michigan; 1978.

5. Miller FD, Hussein M, Mancy KH, and , Hilbert MS. Aspects of Environmental Health Impacts of the Aswan High Dam on Rural Populations in Egypt. Progress in Water Technology 1978; 11((1/2)): 173-80.

7. Miller FD, Mancy KH, King C, Hilbert MS, Hussein M. Schistosome Patterns in Egypt. Lancet 1979; 6: 749.

10. Miller FD. A brief Assessment of Water Supply and Waste Disposal Systems in Developing Countries. Approtech 1980; 3.

11. Miller F, Hussein M, Mancy KH, Hilbert MS, Monto AS, Barakat RM. An epidemiological study of Schistosoma haematobium and S. mansoni infection in thirty-five rural Egyptian villages. Tropical and geographical medicine 1981; 33(4): 355-65.

12. King CL, Miller FD, Hussein M, Barkat R, Monto AS. Prevalence and intensity of Schistosoma haematobium infection in six villages of upper Egypt. The American journal of tropical medicine and hygiene 1982; 31(2): 320-7.

13. Miller FD, El-Hakim SM, Bruce JI. An epidemiological investigation of health risks related to solid waste salvage and recycling in an Egyptian community. Tropical and geographical medicine 1982; 34(3): 241-9.

14. Monto AS, Miller FD, Maassab HF. Evaluation of an attenuated, cold-recombinant influenza B virus vaccine. J Infect Dis 1982; 145(1): 57-64.

15. Miller FD. Problems of water storage in the rural village home: the Egyptian zir. The Journal of tropical medicine and hygiene 1984; 87(2): 53-9.

16. Miller FD, Brilliant LB, Copeland R. Polybrominated biphenyls in lactating Michigan women: Persistence in the population. Bulletin of Environmental Contamination and Toxicology 1984; 32(1): 125-33.

17. Miller FD, Hicks SP, D'Amato CJ, Landis JR. A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. Am J Epidemiol 1984; 120(3): 331-41.

18. Miller FD, Monto AS, DeLong DC, Exelby A, Bryan ER, Srivastava S. Controlled trial of enviroxime against natural rhinovirus infections in a community. Antimicrob Agents Chemother 1985; 27(1): 102-6.

19. Miller FD. Boiling drinking water programs: A critical look. . Waterlines 1986; 5((1)): 2-5.

20. Miller FD. Water consumption and demand measurements for single family households: A pilot approach. . Journal of Environmental Health 1987; 50: 13-7. .

21. Miller FD, Reed DM, MacLean CJ. A prospective study of mortality and morbidity among carpenters in the Honolulu Heart Program Cohort. J Occup Med 1988; 30(11): 879-82.

22. Miller FD, Michael JM. Environmental health education in Micronesia. Asia Pac J Public Health 1989; 3(1): 51-60.

23. Reed D, LaCroix, AZ, Karasek, RA, Miller, D., & MacLean, CA. Occupational strain and the incidence of coronary heart disease. American Journal of Epidemiology 1989; 129((3)): 495-502.

24. Curb JD, Reed DM, Miller FD, Yano K. Health status and life style in elderly Japanese men with a long life expectancy. J Gerontol 1990; 45(5): S206-11.

25. Kloos H, Higashi G, Schinski VD, Mansour NS, Murrell KD, Miller FD. Water contact and Schistosoma haematobium infection: a case study from an upper Egyptian village. Int J Epidemiol 1990; 19(3): 749-58.

27. Kungskulniti N, Pulket C, Miller FD, Smith KR. Solid waste scavenger community: an investigation in Bangkok, Thailand. Asia Pac J Public Health 1991; 5(1): 54-65.

28. Miller FD. Bacterial contamination of water resources on Moen, Truk Islands, Federated States of Micronesia. In: Geological S, University of Hawaii at M, editors. Technical memorandum ;no 83. Honolulu, Hawaii: Water Resources Research Center, University of Hawaii at Manoa; 1991. p. xiii, 45 p.

29. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD. High HCV prevalence in Egyptian blood donors. Lancet 1992; 340(8816): 427.

30. Barakat R, Farghaly A, el-Sawy MF, et al. An epidemiological assessment of Ambrosia maritima on the transmission of schistosomiasis in the Egyptian Nile Delta. Trop Med Parasitol 1993; 44(3): 181-6.

31. Kamel M, Kuhns MC, Miller FD, et al. High hepatitis C seroprevalence and serum viremia with normal alanine aminotransferase levels among blood donors and rural villagers in Egypt. . Hepatology 1993; 18(4(Part 2)).

32. Kamel M, Miller F, Troonen H, Ghaffar YA. Independent association of HBsAg and HCV with hepatocellular carcinoma (HCC) in an area of high endemicity: Egypt. Hepatology 1993; 18(4): 2.

33. Miller FD, Reed DM, Banta J. Sugarcane workers: morbidity and mortality. Hawaii Med J 1993; 52(11): 300-3, 6.

34. Miller FD, Reed DM, MacLean CJ. Mortality and morbidity among blue and white collar workers in the Honolulu Heart Program cohort. Int J Epidemiol 1993; 22(5): 834-7.

35. Kamel M, El Manialawi M, Miller FD. Recombinant hepatitis B vaccine immunogenicity in presence of hepatitis C virus seropositivity. Lancet 1994; 343(8896): 552.

36. Kamel MA, Miller FD, el Masry AG, et al. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 1994; 88(5): 501-9.

37. Barakat R, el Masry AG, Farghaly A, et al. Impact of population-based selective chemotherapy on prevalence and intensity of Schistosoma mansoni infections in the Nile Delta: Kafr El Sheikh. Tropical and geographical medicine 1995; 47(6): 266-70.

38. Barakat R, Farghaly A, el Masry AG, elSayed MK, Husein MH, Miller FD. Schistosoma mansoni in the Nile Delta, Egypt. A large scale epidemiological study in Kafr El Sheikh Governorate. Tropical and geographical medicine 1995; 47(6): 259-65.

39. Barakat R, Farghaly A, Morshidy HN, et al. Patterns of infection, incidence and reinfection with Schistosoma mansoni in Nile Delta Governorate: Kafr El Sheikh. Tropical and geographical medicine 1995; 47(6): 270-7.

40. Kamel MA, Troonen H, Kapprell HP, el-Ayady A, Miller FD. Seroepidemiology of hepatitis E virus in the Egyptian Nile Delta. J Med Virol 1995; 47(4): 399-403.

41. El Sayed MK, Barakat R, Farghaly A, et al. The impact of passive chemotherapy on Schistosoma mansoni prevalence and intensity of infection in the Egyptian Nile Delta. The American journal of tropical medicine and hygiene 1997; 57(3): 266-71.

42. Miller FD. High seroprevalence of hepatitis A, B, C, and E virus in an Egyptian village in the Nile Delta. The American journal of tropical medicine and hygiene 1997; 57(3): 251.

43. Miller FD. Schistosomiasis and Hepatitis C Virus in Egypt. . Health Issues in the Middle East. University of Michigan. Ann Arbor, Michigan.: University of Michigan. Ann Arbor, Michigan.; 1997.

44. Barakat R, Farghaly A, El Morshidy HN, Hassan M, Miller FD. Impact of National Schistosomiasis Control Program in Kafr el Sheikh Governorate, Nile Delta, Egypt: An independent evaluation. Journal of the Egyptian Public Health Association 1998; 73(5,6): 737-53.

45. Rashida Barakat, Azza Farghaly, Hala N. El Morshidy, Mohammed Hassan, Miller FD. Impact of National Schistosomiasis Control Program in Kafr el Sheikh Governorate, Nile Delta, Egypt: An independent evaluation. The Journal of the Egyptian Public Health Association 1998; LXXIII: ((5,6) ): 737-53.

46. Talaat M, Miller FD. A mass chemotherapy trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt. The American journal of tropical medicine and hygiene 1998; 59(4): 546-50.

47. Nerurkar VR, Woodward CL, Nguyen HT, et al. Lack of association between acquisition of TT virus and risk behavior for HIV and HCV infection in Vietnam. Int J Infect Dis 1999; 3(4): 181-5.

48. Talaat M, El-Ayyat A, Sayed HA, Miller FD. Emergence of Schistosoma mansoni infection in upper Egypt: the Giza governorate. The American journal of tropical medicine and hygiene 1999; 60(5): 822-6.

49. El-Khoby T, Hussein MH, Galal N, Miller FD. Epidemiology 1, 2, 3: origins, objectives, organization, and implementation. The American journal of tropical medicine and hygiene 2000; 62(2 Suppl): 2-7.

50. Hussein MH, El-Sayed MK, Talaat M, El-Badawy A, Miller FD. Epidemiology 1, 2, 3: study and sample design. The American journal of tropical medicine and hygiene 2000; 62(2 Suppl): 8-13.

51. Katz AR, Miller FD. The role of epidemiology in graduate medical education. Hawaii Med J 2002; 61(5): 102-3.

52. Lasher LE, Elm JL, Hoang Q, et al. A case control investigation of hepatitis C risk factors in Hawaii. Hawaii Med J 2005; 64(11): 296-300, 2-4.

53. Li F, Park SY, Ayers TL, et al. Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002. Emerg Infect Dis 2005; 11(8): 1205-10.

54. Shimizu SM, Chow DC, Katz AR, Richmond-Crum S, Miller FD. Ethnic differences in HIV disease progression: a comparison of Asian/Pacific Islanders and Whites living in Hawaii. Ethn Dis 2006; 16(1): 262-7.

55. Li F, Arnsberger P, Miller FD. Profile of methicillin-resistant Staphylococcus aureus among nursing home residents in Hawai'i. Hawaii Med J 2010; 69(5): 126-9.

56. Li F, Miller FD, Effler PV. Epidemiology of methicillin-resistant Staphylococcus aureus among incarcerated population in Hawai'i, 2000-2005. Hawaii Med J 2010; 69(4): 99-102.

57. Miller FD. Population incidence estimates for hepatitis C virus infection in Egypt. International Journal of Infectious Diseases 2010; 14(PIIS1201971210004959.pdf): e379.

58. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A 2010; 107(33): 14757-62.

59. Ruth Bastable G, UK, Sylvie Briand c-ootI, Respiratory , Diseases HaPfuatWH, et al. The Silent Pandemic. Tackling Hepatitis C with Policy Innovation. The Economist. 2012.

60. Chemaitelly H, Abu-Raddad LJ, Miller FD. An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt. PLoS One 2013; 8(7): e69803.

61. Miller FD, Abu-Raddad LJ. Quantifying current hepatitis C virus incidence in Egypt. J Viral Hepat 2013; 20(9): 666-7.

62. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013; 13: 288.

63. Cuadros DF, Branscum AJ, Miller FD, Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications. Hepatology 2014; 60(4): 1150-9.

64. Miller FD. Epidemiology and Prevention of HCV in Eygpt. BioVisionAlexandria 2014 Conference Bibliotheca Alexandrina, Alexandria, EgyptInvited Presentation Grand Hall of the Bibliotheca Alexandrina 2014.

65. Mohamoud YA, Miller FD, Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker. World J Gastroenterol 2014; 20(36): 12734-52.

66. Perumalswami PV, Miller FD, Orabee H, et al. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community. Liver international : official journal of the International Association for the Study of the Liver 2014; 34(2): 253-8.

67. Benova L, Awad SF, Miller FD, Abu-Raddad LJ. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology 2015; 61(3): 834-42.

68. Cuadros DF, Branscum AJ, Miller FD, Awad SF, Abu-Raddad LJ. Are Geographical "Cold Spots" of Male Circumcision Driving Differential HIV Dynamics in Tanzania? Front Public Health 2015; 3: 218.

69. Cuadros DF, Miller FD, Nagelkerke N, Abu-Raddad LJ. Association between HCV infection and diabetes type 2 in Egypt: is it time to split up? Ann Epidemiol 2015; 25(12): 918-23.

70. Hassanin FS, Schaalan MF, Kamal KM, Miller FD. An Initial Investigation of Do Not Resuscitate Acceptance in Egypt. American Journal of Hospice and Palliative Medicine 2015.

71. Miller FD, Elzalabany MS, Hassani S, Cuadros DF. Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation. World J Hepatol 2015; 7(28): 2849-58.

72. Chuang E, Lim E, Milne C, et al. Human Papillomavirus at Multiple Sites Associated with Anal Squamous Intraepithelial Lesions in HIV-Seropositive Individuals. Ann Clin Cytol Pathol 2016; 2(4).

73. Hassanin FS, Schaalan MF, Kamal KM, Miller FD. An Initial Investigation of Do Not Resuscitate Acceptance in Egypt. Am J Hosp Palliat Care 2016; 33(9): 823-8.

74. Miller FD. Hepatitis C virus in Arabian Gulf countries: Implications and priorities. Int J Infect Dis 2016; 46: 115.

75. Mohsen DA, Hosny S, Morshedy N, Miller FD, Elzalabany MS. Prevalence of Hepatitis C Virus Infection in Egyptian Patients with Rheumatoid Arthritis ACR 2017; (Abstract).

76. Soliman G, Negm MS, Elzalabany M, et al. Is treatment of hepatitis C with controlled generic direct acting antiviral drugs effective? An Egyptian experience. Journal of Hepatology 2018; 68: S276.

77. Soliman G, Negm MS, Elzalabany MS, et al. High efficacy and safety of sofosbuvir plus daclatasvir for treatment of hepatitis C virus genotype 4: a real life Egyptian experience. Submitted 2018.

78. Miller FD. Adapting Epidemologic Methods to Investigate Iatrogenic Transmission and Evaluate Interventions in Egypt: Understanding Exposure Epidemiology. Alex-Health 2019. Alexandria, Egypt; 2019.

79. Soliman G, Elzalabany MS, Hassanein T, Miller FD. Mass screening for hepatitis B and C in Southern Upper Egypt. BMC Public Health 2019; 19(1): 1326.

80. Cuadros DF, Miller FD. Barriers Associated with Effective Use of Insecticide Treated Nets and Geographical Identification of Vulnerable Children at Risk of Malaria in sub-Saharan Africa. Malaria Journal 2020.

81. Hernandez A, Correa-Agudelo E, Kim H, et al. On the impact of early non-pharmaceutical interventions as containment strategies against the COVID-19 pandemic. Journal of Infection 2020; YJINF-D-20-02111.

64. Miller FD. Epidemiology and Prevention of HCV in Eygpt. BioVisionAlexandria 2014 Conference Bibliotheca Alexandrina, Alexandria, Egypt
Invited Presentation Grand Hall of the Bibliotheca Alexandrina 2014.